Genomics is that field of science which is focused on the understanding of genomes and their interaction between different stimuli. This area has been in demand ever since the scientists and various biotechnology organizations understood the significant benefits behind the understanding of genomes are directly related to their understanding of the environment. This study utilizes various bioinformatics, DNA sequencing methods, and various forms of recombinant DNA for the assembly, analysis and understanding the structure of genomes in the environment.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-genomics-market
The main factors behind the growth of the market are:
The market is segmented on the basis of product & services as instruments/systems, consumables, services; technology as sequencing, microarray, PCR, nucleic acid extraction & purification; application is segmented into diagnostics, drug discovery & development, precision medicine, agriculture & animal research; process is categorized into sequencing, library, preparation, data analysis; end-user is categorized into research centers, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, others.
Some of the recent market developments are as follows:
“According to Data Bridge Market Research, global genomics market is growing at a substantial CAGR of 9.5% during the forecast period of 2017 to 2024”
Some of the major players operating in the market are General Electric, Danaher, Thermo Fisher Scientific Inc., F. Hoffman-La Roche Ltd, Illumina, Inc., QIAGEN, Merck & Co., Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Genotypic Technology Pvt Ltd, Macrogen, Inc., Eurofins Scientific, PerkinElmer Inc., Personalis Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Eppendorf AG, Novogene Corporation, SciGenom Labs Pvt. Ltd, TAKARA HOLDINGS INC., Kohlberg Kravis Roberts & Co. L.P., GENEWIZ, Genomatix GmbH, Biomatters Limited, Strand Life Sciences Pvt. Ltd., DNASTAR, Inc. and New England Biolabs among others.
With a significant prevalence of chronic and rare life-threatening diseases, there is a need for development of personalized effective therapeutics. This process is fulfilled through a number of scientific technologies, and although a number of variations in technologies are available; various biotechnology organizations prefer the usage of genomics to achieve this personalization as it is a highly advanced technological solution and provides highly effective conclusive results.
Global Genomics Market - Industry Trends and Forecast to 2026
Global Nutrigenomics Market – Industry Trends and Forecast to 2026
Global Spatial Genomics Market – Industry Trends and Forecast to 2027
Global Metagenomics Market – Industry Trends and Forecast to 2027
Global Consumer Genomics Market – Industry Trends & Forecast to 2026
Global Function Driven Metagenomics Market – Industry Trends and Forecast to 2026
Global Sequencing Driven Metagenomics Market – Industry Trends and Forecast to 2026
Global Pharmacogenomics Market – Industry Trends and Forecast to 2027